Sfoglia per AUTORE
DOGLIOTTI I
Collezione AOU San Luigi di Orbassano
Items : 2
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2016 Aug;16 Suppl:S96-S100. doi: 10.1016/j.clml.2016.03.008. Epub 2016 A
2016
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Fava C; Rege-Cambrin G; Dogliotti I; Gottardi E; Berchialla P; Di Gioacchino B; Crasto F; Lorenzatti R; Volpengo A; Daraio F; Fantino C; Saglio G;
Update on emerging treatments for chronic myeloid leukemia. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2015 Jun;20(2):183-96. doi: 10.1517/14728214.2015.1031217. Epub 2015 Mar 31
2015
AOU San Luigi di Orbassano
AOU San Luigi di Orbassano
Fava C; Morotti A; Dogliotti I; Saglio G; Rege-Cambrin G;